Bullous lesions in a patient with panesclerotic morphea of the childhood

Authors

  • Lola Kuperman Wilder J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • Candela Preti J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • César Chiappe J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • Gabriela Bendjuia J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v27i3.2127

Keywords:

morphea, bullae, bullous lichen sclerosus

Abstract

Bullous morphea is an infrequent type of morphea characterized for developing bullae on sclerodermiformic plaques. The presence of bullae forces to discard lichen sclerosus, a disease that usually develops in the genital zone, the extragenital variant could belong to the same spectrum that localized sclerodermiformic diseases. We present a 19 year old female patient with the diagnosis of panesclerotic morphea and bullous lichen sclerosus.

Author Biographies

  • Lola Kuperman Wilder, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

    Resident Physician

  • Candela Preti, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

    Dermatologist, Collagen Diseases Sector

  • César Chiappe, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

    Pathologist

  • Gabriela Bendjuia, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

    Dermatologist, Collagen Diseases Sector

References

I.. Sánchez-Pérez S, Escandell-González I, Pinazo-Canales MI, Jordá-Cuevas E. Bullous morphea: description of a new case and discussion of etiologic and pathogenic factors in bulla formation. Actas Dermosi liogr. 2017;108:75-76.

II. Daoud MS, Su WP, Leiferman KM, Perniciaro C. Bullous morphea: Clinical, pathological and immunopathologic evaluation of thirteen cases. J Am Acad Dermatol. 1994;30:937-943.

III. Uitto J, Santa Cruz DJ, Bauer EA, Eisen AZ. Morphea and lichen sclerosus et atrophicus. Clinical and histopathologic studies in patients with combined features. J Am Acad Dermatol. 1980;3:271-279.

IV. Yasar S, Mumcuoglu CT, Serdar ZA, Gunes P. A case of lichen sclerosus et atrophicus accompanying bullous morphea. Ann Dermatol. 2011;23:354-359.

V. López Bertrán JM, Renis FM, Stefanazzi MH, Simionato C, et ál. Liquen escleroso extragenital ampollar y hemorrágico: a propósito de un caso [en línea]. Rev Argent Dermatol. 2010;91(3). [Consultado marzo 2021].

Rencic A, Goyal S, Mofid M, Wigley F, et ál. Bullous lesions scleroderma. Int J Dermatol. 2020;41:335-339.

VII. Mertens JS, Marsman D, Van de Kerkhof PC, https://pubmed. ncbi.nlm.nih.gov/12100687/ Hoppenreijs EP, et ál. Use of mycophenolate mofetil in patients with severe localized scleroderma resistant or intolerant to methotrexate. Acta Derm Venereol. 2016;96:510-513.

VIII. Arthur M, Fett NM, Latour E, Jacobe H, et ál. Evaluation of the e ectiveness and tolerability of mycophenolate mofetil and mycophenolic acid for the treatment of morphea. JAMA Dermatol. 2020;156: 521-528.

Downloads

Published

2021-09-18

Issue

Section

Clinical Cases